Published in
Wiley, American Journal of Transplantation, 10(21), p. 3465-3471, 2021
DOI: 10.1111/ajt.16628
Links
Tools
Successful treatment of Epstein–Barr virus–associated primary central nervous system lymphoma due to post-transplantation lymphoproliferative disorder, with ibrutinib and third-party Epstein–Barr virus–specific T cells
Journal article published in 2021 by
Soi C. Law 
,
Thanh Hoang,
Kacey O’Rourke,
Joshua W. D. Tobin ,
Jay Gunawardana ,
Dorothy Loo-Oey,
Karolina Bednarska ,
Lilia Merida de Long ,
Muhammed B. Sabdia ,
Greg Hapgood ,
Emily Blyth ,
Leighton Clancy,
Stefanie Hennig ,
Colm Keane ,
Maher K. Gandhi
,
Thanh Hoang,
Kacey O’Rourke,
Joshua W. D. Tobin ,
Jay Gunawardana ,
Dorothy Loo-Oey,
Karolina Bednarska ,
Lilia Merida de Long ,
Muhammed B. Sabdia ,
Greg Hapgood ,
Emily Blyth ,
Leighton Clancy,
Stefanie Hennig ,
Colm Keane ,
Maher K. Gandhi
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 